Nor in Biological Technology
Navigation Links
Nor in Biological Technology
...www.sec.gov .
This communication shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualific...
...aterially from those projected herein. Medicago disclaims any obligation to update these forward-looking statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accu...
...e systems." As we note in our formal comments, "Certifying an EHR does not necessarily equate with effectively using the system's available functions nor does implementation of a certified product necessarily achieve or ensure actual changes in either clinical practice or patient outcomes. The potential...
...lace through a bookbuilding process and was managed by Carnegie ASA and DnB nor Markets as joint-lead managers and joint bookrunners. The Private Placement...all not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdi...
...g. Continued treatment for prolonged periods was very well tolerated and there was no evidence of Grade III or IV rash at any of the three dose levels nor did nimotuzumab increase the toxicity of radiotherapy. Based on these results, YM is currently conducting an international 128-patient Phase II random...
...elivery when the person needs them in the future. Compared to embryonic stem cells, these cells are one's own and are not subject to risk of rejection nor require immune suppressing drugs and could remove any ethical dilemmas surrounding embryonic stem cell research or treatment. The Company anticipates...
...cker: CLAVIS). Disclaimer The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to ...
ADVENTRX Pharmaceuticals Announces Financing
... exclusive placement agent for the transaction. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registrati...Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
...ger for the offering. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Idenix, nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registratio...Micromet Closes $80.5 Million Public Offering of Common Stock
... Curhan Ford as co-managers in this offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to t...Human Genome Sciences Announces Closing of Public Offering
...tement. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Human Genome Sciences, Inc., nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registratio...CuraGen Reports Second Quarter 2009 Financial Results
...his communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualifi...TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction
...his communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualifi...Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
...for SNS-01." Important Information This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualific......aterially from those projected herein. Medicago disclaims any obligation to update these forward-looking statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accu...
Micromet Announces Pricing of Public Offering of Common Stock
...with the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to t...Micromet Announces Public Offering of Common Stock
... with the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to t...Sanofi-aventis Announces Second Quarter 2009 Results
...ation with chemotherapy in women with metastatic triple negative breast cancer (mTNBC), i.e. with a tumor that expresses neither the estrogen receptor nor the progesterone receptor and does not over-express the HER2 receptor. Enrolment to the Phase III study, evaluating NV1FGF in critical ischemia...Human Genome Sciences Announces Pricing of Public Offering of Common Stock
...tement. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Human Genome Sciences, Inc., nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registratio...Human Genome Sciences Announces Proposed Public Offering of Common Stock
.... This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Human Genome Sciences, Inc., nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registratio...Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
... effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration ...OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
...ief Financial Officer. This news release shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of OncoGenex, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registra...Cell Therapeutics, Inc. Announces Exercise of Overallotment
...251 Avenue of the Americas, 20th Floor, New York, New York 10020, or by calling (212) 356-0549. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of our shares of common stock or warrants. No offer, solicitation or sale will be made in any jurisdiction in w...Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
...mmission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement ...hall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in...Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
...251 Avenue of the Americas, 20th Floor, New York, New York 10020, or by calling (212) 356-0549. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of our shares of common stock or warrants. No offer, solicitation or sale will be made in any jurisdiction in w...OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
...nned once a partnership for OGX-011 is secured." This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registra...Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
...ing the shares issuable upon exercise of the warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration ...Pharmacyclics Announces Subscription Price for Rights Offering
...aylight Time, unless extended by the Company. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qual......e systems." As we note in our formal comments, "Certifying an EHR does not necessarily equate with effectively using the system's available functions nor does implementation of a certified product necessarily achieve or ensure actual changes in either clinical practice or patient outcomes. The potential...
Progenitor Cell Therapy Appoints VP of Manufacturing Operations
...ooking statements are reasonable, it cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither the company nor any other person assumes responsibility for the accuracy and completeness of such statements. The company is under no duty to update any of the forwar...Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
...ial for SNS-01." Important Information This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualific...Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement
...ing the shares issuable upon exercise of the warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration ...Verenium Completes Amendment to 8% Senior Convertible Notes
..., 2009 with the Securities and Exchange Commission. This press release is not an offer to sell or the solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. About Verenium ...Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
...ny forward-looking statements as a result of new information or future events or developments. This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Cougar Biotechnology, Inc. Johnson & Johnson has filed a tender offer statement with the SEC, and has...Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
...ubsequent filings, are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson. Neither Centocor Ortho Biotech Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments. ...OncoGenex Pharmaceuticals Files Shelf Registration Statement
...on but they have not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the shelf registration stat...all not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdict...Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane
...r or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore. Syngenta Biotechnology, Inc. Media contact...Syngenta and Evogene to Collaborate on Soybean Nematode Resistance
...r or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefore. Media contact: Jane Bachmann +1 919 531 853......lace through a bookbuilding process and was managed by Carnegie ASA and DnB nor Markets as joint-lead managers and joint bookrunners. The Private Placement...all not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdi...
AEterna Zentaris Receives US$10 Million from Institutional Investors
... directly from AEterna Zentaris Inc., 1405 du Parc-Technologique Boulevard, Quebec City, Canada G1P 4P5. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of AEterna Zentaris' common shares or warrants. No offer, solicitation or sale will be made in any jurisdiction ...CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
...ctive by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registrat......g. Continued treatment for prolonged periods was very well tolerated and there was no evidence of Grade III or IV rash at any of the three dose levels nor did nimotuzumab increase the toxicity of radiotherapy. Based on these results, YM is currently conducting an international 128-patient Phase II random...
Syngenta Issues EUR 500 Million Eurobond
...r or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor. ......elivery when the person needs them in the future. Compared to embryonic stem cells, these cells are one's own and are not subject to risk of rejection nor require immune suppressing drugs and could remove any ethical dilemmas surrounding embryonic stem cell research or treatment. The Company anticipates...
Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
...y forward-looking statements as a result of new information or future events or developments. This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of Cougar Biotechnology, Inc. Johnson & Johnson has filed a tender offer statement with the SEC, and has......cker: CLAVIS). Disclaimer The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to ...
Other TagsOther Contentsnucleinucleinucleinucleinucleinucleipolarpolarpolarpolarpolargraingraingraingraingraingrainpollenpollenpollenpollentailtailtailtailtailpolyacrylamidepolyacrylamidepolyacrylamidepolyacrylamidepolyadenylationpolyadenylationpolyadenylationantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodiesantibodies
(Date:11/26/2009)...tlers, red deer have been caught in the hunters, s...ch more than decorative. They are lethal weapons t...y, from The University of York, UK, has been intri... half a century and has become fascinated by the m...ding collaboration with Tomas Landete-Castillejos ...
(Date:11/26/2009)...European countries has shown that closing schools ...ld have a significant role in reducing illness tra...journal BMC Infectious Diseases compared opportu...olidays, finding that they were reduced when schoo...rp University, Belgium, led a team of European res...
(Date:11/26/2009)...09 What are the bare essentials of life, the indi...hat can survive on its own? Can we describe the mo...ntire organism functions as a system? These are ju...nership between the European Molecular Biology Lab...tre de Regulacio Genmica (CRG) in Barcelona, Spain...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3NIST demonstrates universal programmable quantum processor 14841 1NIST demonstrates universal programmable quantum processor 14841 2NIST demonstrates universal programmable quantum processor 14841 3NIST demonstrates universal programmable quantum processor 14841 4World Champion New York Yankees BNY Mellon to be Honored as New York Blood Center Champions of Life 61383 1World Champion New York Yankees BNY Mellon to be Honored as New York Blood Center Champions of Life 61383 2Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 1Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 2Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 3Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 4Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 5Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 6Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 7Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 8Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 9Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 10Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 11Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 12Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 13Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 14Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14840 15(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...re letters from the North Pole, Textsanta.net lets...om Santa , North Pole, AK...fficiencies at the North Pole Santa Claus has adde...r the globe informed of his Christmas progress at ...h department have identified a large and growing p...
(Date:11/26/2009)...n Communications announces a highly effective and ...s struggling to make an economic recovery. , ...lu fears is the type of challenge that could send ...ing to Dr. David Benton, business growth expert an...tem – The Rfactor Intensive . “Fear...
(Date:11/25/2009)...Nov. 25 The Bartle Hall Convention...st medical clinic on Dec. 9-10, when Kansas City h...s for uninsured people. ,, "This free clinic ev...ecause it will extend over two days instead of jus...ekend," Sheri Wood, executive director of the Kans...
(Date:11/25/2009)...RNewswire/ - Sentinelle Medical Inc., a leading ma...ization software launches a suite of new leading e... imaging software platform at this year,s Radiolog...g in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, ... quality images generated by Sentinelle,s speciali...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4[1] Research sheds light on workings of anti-cancer drug[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes[1] Pharmacist Injects Cure for Ailing Businesses [1] Kansas City Prepares for Largest Free Health Clinic[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |